Abstract
T lymphoma invasion and metastasis 1 (Tiam1) is a metastasis-related gene of T lymphoma that is also involved in the metastasis of a variety of other cancers, but little research has been done yet to test its usefulness as a prognostic marker in renal cell carcinoma (RCC). In the present study, we investigated Tiam1 expression and its prognostic significance in RCC. RCC surgical tissue samples were taken from 136 patients with RCC who had been followed up for 5 years. The Tiam1 expressions in the 136 clinical samples were tested by immunohistochemical assay to find their association with prognostic significance. We found that 93 of 136 (68.4%) paraffin-embedded archival RCC biopsies showed positive expression of Tiam1. Statistical analysis showed that there was significant difference of Tiam1 overexpression in patients categorized according to lymph node metastasis. Patients with higher Tiam1 expression had shorter overall survival time, whereas patients with lower Tiam1 expression had better survival. Multivariate analysis showed that Tiam1 overexpression was an independent prognostic indicator for patient’s survival. Our results suggest that Tiam1 protein is a valuable marker of RCC progression. High Tiam1 expression is associated with poor overall survival in patients with RCC.
Similar content being viewed by others
References
Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628–1631
Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF et al (2004) Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 10:184–190
Ding Y, Chen B, Wang S, Zhao L, Chen J, Ding Y et al (2009) Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients. Int J Cancer 124:653–658
Engers R, Mueller M, Walter A, Collard JG, Willers R, Gabbert HE (2006) Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br J Cancer 95:1081–1086
Ficarra V, Novara G, Galfano A, Artibani W (2004) Neoplasm staging and organ-confined renal cell carcinoma: a systematic review. Eur Urol 46:559–564
Habets GG, Scholtes EH, Zuydgeest D, van der Kammen RA, Stam JC, Berns A et al (1994) Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77:537–549
Hou M, Tan L, Wang X, Zhu YS (2004) Antisense Tiam1 down-regulates the invasiveness of 95D cells in vitro. Acta Biochim Biophys Sin (Shanghai) 36:537–540
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10–30
Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P (2001) A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166:63–67
Lam JS, Belldegrun AS, Figlin RA (2004) Advances in immune-based therapies of renal cell carcinoma. Expert Rev Anticancer Ther 4:1081–1096
Lam JS, Leppert JT, Figlin RA, Belldegrun AS (2005a) Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep 6:7–18
Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS (2005b) Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 173:1853–1862
Landis S, Murray T, Bolden S, Wingo P (1999) Cancer statistics, 1999. CA Cancer J Clin 49:8–31
Lane BR, Li J, Zhou M, Babineau D, Faber P, Novick AC et al (2009) Differential expression in clear cell renal cell carcinoma identified by gene expression profiling. J Urol 181:849–860
Liu L, Zhang Q, Zhang Y, Wang S, Ding Y (2006) Lentivirus-mediated silencing of Tiam1 gene influences multiple functions of a human colorectal cancer cell line. Neoplasia 8:917–924
Malliri A, van der Kammen RA, Clark K, van der Valk M, Michiels F, Collard JG (2002) Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 417:867–871
Minard ME, Kim LS, Price JE, Gallick GE (2004) The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat 84:21–32
Minard ME, Herynk MH, Collard JG, Gallick GE (2005) The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene 24:2568–2573
Motzer R, Russo P, Nanus D, Berg W (1997) Renal cell carcinoma. Curr Probl Cancer 21:185–232
Negrier S, Escudier B, Gomez F, Douillard JY, Ravaud A, Chevreau C et al (2002) Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d’Immunotherapie. Ann Oncol 13:1460–1468
Patel PH, Chaganti RS, Motzer RJ (2006) Targeted therapy for metastatic renal cell carcinoma. Br J Cancer 94:614–619
Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M et al (2005) A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173:48–51
Zhao L, Wang H, Li J, Liu Y, Ding Y (2008) Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer. J Proteome Res 7:3994–4003
Acknowledgments
This work was financially supported by Key Science and Technology Research Program of Guangdong Province (No.2003A308401) and National Natural Science Foundation of China (No. 30901792).
Conflict of interest statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Liang Zhao and Yawei Liu have contributed equally.
Rights and permissions
About this article
Cite this article
Zhao, L., Liu, Y., Sun, X. et al. Overexpression of T lymphoma invasion and metastasis 1 predict renal cell carcinoma metastasis and overall patient survival. J Cancer Res Clin Oncol 137, 393–398 (2011). https://doi.org/10.1007/s00432-010-0895-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-010-0895-7